awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47657861-2B60321D-920C-41D1-8DE7-34BE8D7538D6
Q47657861-2B60321D-920C-41D1-8DE7-34BE8D7538D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47657861-2B60321D-920C-41D1-8DE7-34BE8D7538D6
Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.
P2860
Q47657861-2B60321D-920C-41D1-8DE7-34BE8D7538D6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47657861-2B60321D-920C-41D1-8DE7-34BE8D7538D6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2c6800aed9bc3055b1543bfa14a4ab86041d9f93
P2860
One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium ste